Related Experiment Video
Updated: May 19, 2026
11:03
Conditional Genetic Transsynaptic Tracing in the Embryonic Mouse Brain
Published on: December 22, 2014
Restricted transgene expression in the brain with cell-type specific neuronal promoters
Aurélie Delzor1, Noelle Dufour, Fanny Petit
1Atomic Energy Commission (CEA), Institute of Biomedical Imaging (I2BM) and Molecular Imaging Research Center (MIRCen), 92265 Fontenay-aux-Roses, France.
Human Gene Therapy Methods
|September 1, 2012
Summary
Researchers analyzed neuronal promoters for targeted gene expression in neurodegenerative disease research. They found significant diversity in promoter activity and cell-type specificity, identifying key promoters for specific brain regions and disease conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Gene Therapy
Background:
- Studying cellular subpopulations in neurodegenerative diseases requires tissue-targeted gene expression.
- Existing in vivo methods for achieving cell-specific expression in the nervous system are limited.
- Developing precise tools for neuronal gene delivery is crucial for understanding and treating neurological disorders.
Purpose of the Study:
- To analyze the cell specificity and transcriptional activity of six neuronal promoters using lentiviral vectors (LVs).
- To compare promoter performance in different brain regions (striatum and hippocampus) in rodents.
- To evaluate promoter regulation under disease conditions for potential therapeutic applications.
Main Methods:
- Quantitative analysis of AcGFPnuc reporter gene expression driven by six neuronal promoters and a reference PGK promoter.
- Lentiviral vector (LV) delivery into the striatum and hippocampus of rodents.
- Assessment of promoter activity, cell-type specificity, and regional expression patterns.
Main Results:
- All tested LV vectors demonstrated neuronal tropism, but with significant variation in transcriptional activity and specificity.
- GAD67, Dlx5/6, GluR1, and Tac1 promoters showed high activity; NSE and Drd1a showed weak activity, improved by an amplification system.
- Tac1 and Drd1a expression in the striatum extended beyond the expected striatonigral pathway, while Drd1a and Dlx5/6 were restricted in the hippocampus. Dlx5/6 promoter activity was modulated by disease, unlike Tac1.
Conclusions:
- Neuronal promoters exhibit diverse expression profiles, offering potential for cell-specific gene targeting in the CNS.
- Selected promoters (e.g., Dlx5/6, Tac1) show promise for targeted gene delivery, with Dlx5/6 responsive to disease states.
- These LV-based tools offer improved selectivity for therapeutic molecule delivery, though further characterization of neuronal promoter elements is needed.
